Small molecule for type 2 diabetes
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
92
NCT05409924
First-in-human Single and Multiple Dose Trial of ATR-258
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 11, 2022
Completion: Oct 4, 2023
NCT06432673
The Attractive 2 Trial - Pharmacokinetics of ATR-258 Oral Capsule vs. Oral Solution Formulations in Healthy Volunteers
Start: Apr 24, 2024
Completion: May 27, 2024
Loading map...